No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Top Premarket Decliners
Addex Therapeutics Ltd (ADXN) Q3 2024 Earnings Call Transcript Summary
Addex Therapeutics Ltd (ADXN) Q3 2024 Earnings Call Transcript
Addex Therapeutics Reports Substantial Asset Growth
Earnings Scheduled For November 22, 2024
Addex Therapeutics Reported Q3 EPS Of CHF(0.02) Up From CHF(0.03), Cash Balance Of CHF3.35M
No Data